Anger, G.J., Cressman, A.M. & Piquette-Miller, M. (2012). Expression of ABC efflux transporters in placenta from women with insulin-managed diabetes. PLoS One 7(4), e35027.
Arques, O., Chicote, I., Tenbaum, S., Puig, I. & Palmer, H.G. (2012). Standardized Relative Quantification of Immunofluorescence Tissue Staining. Protocol Exchange (Nature), doi:10.1038/protex.2012.008.
Blot, V. & McGraw, T.E. (2008). Use of quantitative immunofluorescence microscopy to study intracellular trafficking. Methods Mol Biol 457, 1–20.
Bogush, T., Tikhomirov, M., Dudko, E., Sinitsyna, M., Ramanauskaite, R., Polotsky, B., Tjulandin, S. & Davydov, M. (2012). Quantitative immunofluorescence estimation of Pgp expression in human solid tumors by flow cytometry. Moscow Univ Chem Bull 67(3), 142–148.
Colombo, P.C., Ashton, A.W., Celaj, S.T., Ashok, B., Javier, E., Dubois Nicholas, B., Marinaccio, M., Malla, S., Lachmann, J., Ware, J.A. & Le Jemtel, T.H. (2002). Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J Appl Physiol 92(3), 1331–1338.
Cook, J.A., Feng, B., Fenner, K.S., Kempshall, S.L., Ray, R.C., Smith, D.A., Troutman, M.D., Ullah, M. & Lee, C.A. (2009). Refining the in vitro and in vivo critical parameters for p-glycoprotein, [I]/IC50 and [I2]/IC50, that allow for the exclusion of drug candidates from clinical digoxin interaction studies. Mol Pharm 7(2), 398–411.
Dietrich, C.G., Geier, A. & Oude Elferink, R.P.J. (2003). ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 52(12), 1788–1795.
Eriksson, A.H., Rønsted, N., Güler, S., Jäger, A.K., Sendra, J.R. & Brodin, B. (2012). In-vitro evaluation of the P-glycoprotein interactions of a series of potentially CNS-active Amaryllidaceae alkaloids. J Pharm Pharmacol 64(11), 1667–1677.
Feng, B., Mills, J.B., Davidson, R.E., Mireles, R.J., Janiszewski, J.S., Troutman, M.D., de Morais, S.M. (2008). In vitro p-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Drug Metab Dispos 36(2), 268–275.
Gabrielsson, J. & Weiner, D. (1997). Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications. Stockholm: Pharmaceutical Press.
Godin, A.G., Costantino, S., Lorenzo, L.-E, Swift, J.L., Sergeev, M., Ribeiro-da-Silva, A., De Koninck, Y. & Wiseman, P.W. (2011). Revealing protein oligomerization and densities in situ using spatial intensity distribution analysis. Proc Natl Acad Sci 108(17), 7010–7015.
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.P., Von Richter, O. & Zundler, J. (1999). The role of intestinal p-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104(2), 147–153.
Hirabayashi, H., Sugimoto, H., Matsumoto, S., Amano, N. & Moriwaki, T. (2011). Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography-tandem mass spectrometry: The usefulness of negative ionization mode to avoid competitive adduct-ion formation. J Chromatogr B Analyt Technol Biomed Life Sci 879(32), 3837–3844.
Kirkpatrick, D.S., Gerber, S.A. & Gygi, S.P. (2005). The absolute quantification strategy: A general procedure for the quantification of proteins and post-translational modifications. Methods 35(3), 265–273.
Krasznai, Z.T., Friedlander, E., Nagy, A., Szabo, G., Vereb, G., Goda, K. & Hernadi, Z. (2005). Quantitative and functional assay of MDR1/P170-mediated MDR in ascites cells of patients with ovarian cancer. Anticancer Res 25(2A), 1187–1192.
Litman, T., Zeuthen, T., Skovsgaard, T. & Stein, W.D. (1997). Structure-activity relationships of P-glycoprotein interacting drugs: Kinetic characterization of their effects on ATPase activity. Biochim Biophys Acta 1361(2), 159–168.
Löscher, W. & Potschka, H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. Neurotherapeutics 2(1), 86–98.
McMullen, R.L., Bauza, E., Gondran, C., Oberto, G., Domloge, N., Farra, C.D. & Moore, D.J. (2010). Image analysis to quantify histological and immunofluorescent staining of ex vivo skin and skin cell cultures. Int J Cosmet Sci 32(2), 143–154.
Miliotis, T., Ali, L., Palm, J.E., Lundqvist, A.J., Ahnoff, M., Andersson, T.B. & Hilgendorf, C. (2011). Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function. Drug Metab Dispos 39(12), 2440–2449.
Mokin, M. & Keifer, J. (2006). Quantitative analysis of immunofluorescent punctate staining of synaptically localized proteins using confocal microscopy and stereology. J Neurosci Methods 157(2), 218–224.
Polli, J.W., Wring, S.A., Humphreys, J.E., Huang, L., Morgan, J.B., Webster, L.O. & Serabjit-Singh, C.S. (2001). Rational use of in vitro p-glycoprotein assays in drug discovery. J Pharmacol Exper Ther 299(2), 620–628.
Rautio, J., Humphreys, J.E., Webster, L.O., Balakrishnan, A., Keogh, J.P., Kunta, J.R., Serabjit-Singh, C.J. & Polli, J.W. (2006). In vitro P-glycoprotein inhibition assays for assessment of clinical drug ineraction potential of new drug candidates: A recommendation for probe substrates. Drug Metab Dispos 34(5), 786–792.
Scarborough, G. (1995). Drug-stimulated ATPase activity of the human P-glycoprotein. J Bioenerg Biomembr 27(1), 37–41.
Taub, M.E., Podila, L., Ely, D. & Almeida, I. (2005). Functional assessment of multiple p-glycoprotein probe substrates: Influence of cell line and modulator concentration on p-gp activity. Drug Metab Dispos 33(11), 1679–1687.
